- Home
- HFRO vs AMRN Comparison
HFRO vs AMRN Comparison
Compare HFRO & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HFRO | AMRN |
|---|---|---|
| Founded | 2000 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 393.9M | 342.8M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | HFRO | AMRN |
|---|---|---|
| Price | $7.46 | $15.46 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 206.0K | 89.5K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | ★ 8.87% | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $5.03 | $12.96 |
| 52 Week High | $7.60 | $20.90 |
Technical Indicators
Market Signals| Indicator | HFRO | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 69.04 | 50.30 |
| Support Level | $6.23 | $13.58 |
| Resistance Level | N/A | $17.04 |
| Average True Range (ATR) | 0.19 | 0.84 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 84.13 | 22.44 |
Price Performance
Historical ComparisonAbout HFRO Highland Opportunities and Income Fund of Beneficial Interest
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.